Most Utahns want to protect Bears Ears. Trump slashed it anyway.

Much like Endgame was the culmination of the MCU’s multi-phase Infinity Saga, Doomsday and its sequel, Secret Wars, are the concluding chapters of the franchise’s six-year-long Multiverse Saga. After Endgame ushered in major status quo changes with the departure of Chris Evans and Robert Downey Jr. (both of whom are now returning), it wasn’t immediately…

A new study investigates whether F16 fighter pilots demonstrate brain connectivity changes that could be expected in astronauts, based on similar exposure to changes in g-forces. The study found that the pilots showed key changes in brain connectivity and they may function as suitable test subjects to learn more about space travel. One cannot explore…

https://preview.redd.it/60a3bqb0v8dh1.png?width=544&format=png&auto=webp&s=00f6e73bdc000a3ee19ff4509ec7ab0d5e69e737 I know M⊙ means solar mass (x * the mass of our sun) but what does that M with a little star mean? Paper: Morpho-kinematic of galaxies at cosmic noon submitted by /u/Raeinnn [comments]

Samsung Electronics (SSNLF), a global technology company with major smartphone and chip businesses, is stepping up its push into robotics as artificial intelligence makes machines increasingly capable of handling complex tasks. The company said Tuesday that it will create a new RX Business Office reporting directly to co-Chief Executive Officer Roh Tae-moon, while bringing its…

NASA’s planned nuclear-powered mission to Mars is expected to cost more than $2 billion, as the agency pushes ahead with what would become the first demonstration of nuclear electric propulsion in space, Politico writes. The mission, known as Space Reactor-1 Freedom (SR-1 Freedom), is projected to cost around $2.1 billion, according to NASA, although the…

Cathie Wood’s ARK Genomic Revolution ETF (NYSEMKT: ARKG) focuses on companies in the genomics sector, especially in healthcare. Since the beginning of July, Wood has, through this Ark Invest exchange-traded fund (ETF), bought $15.3 million worth of Ionis Pharmaceuticals (NASDAQ: IONS), a biotech company based in Carlsbad, California. The stock is down nearly 37% from…